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Abstract
Background: Exercise referral schemes are recommended by the National Institute for Clinical Excellence (NICE) for
physical activity promotion among inactive patients with health conditions or risk factors. Whilst there is evidence
for the initial effectiveness and cost-effectiveness of such schemes for increasing physical activity, evidence of long-
term effects is limited. Techniques such as goal setting, self-monitoring and personalised feedback may support
motivation for physical activity. Technologies such as activity monitoring devices provide an opportunity to enhance
delivery of motivational techniques. This paper describes the PACERS study protocol, which aims to assess the
feasibility and acceptability of implementing an activity monitor within the existing Welsh National Exercise Referral
Scheme (NERS) and proposed evaluation methodology for a full-scale randomised controlled trial.
Methods/design: The PACERS study consists of a pilot randomised controlled trial, process evaluation and exploratory
economic analyses. Participants will be recruited from the generic pathway of the Welsh NERS and will be randomly
assigned to receive the intervention or usual practice. Usual practice is a 16-week structured exercise programme; the
intervention consists of an accelerometry-based activity monitor (MyWellnessKey) and an associated web platform
(MyWellnessCloud). The primary outcomes are predefined progression criteria assessing the acceptability and feasibility
of the intervention and feasibility of the proposed evaluation methodology. Postal questionnaires will be completed at
baseline (time 0: T0), 16 weeks after T0 (T1) and 12 months after T0 (T2). Routinely collected data will also be accessed
at the same time points. A sub-sample of intervention participants and exercise referral staff will be interviewed
following initiation of intervention delivery and at the end of the study.
Discussion: The PACERS study seeks to assess the feasibility of adding a novel motivational component to an existing
effective intervention in order to enhance effects on physical activity and support longer-term maintenance. The study
will provide insight into the acceptability of activity-monitoring technologies to an exercise referral population and
delivery staff. Data from this study will be used to determine whether and how to proceed to a full-scale trial of
effectiveness of the intervention, including any necessary refinements to intervention implementation or the proposed
evaluation methodology.
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Background
Physical inactivity is a major cause of preventable illness
with large costs to the National Health Service (NHS) [1].
Increasing activity at the population level and among at-
risk groups is a public health priority [2, 3]. Physical activ-
ity interventions for at-risk groups often involve advice
and/or signposting from primary care practitioners [4].
Exercise referral schemes (ERS) are one common model
[5], usually involving referral to a community-based struc-
tured exercise programme. In Wales, the 16-week Na-
tional Exercise Referral Scheme (NERS) has been running
since 2007. A previous effectiveness study of the scheme
[6] showed that, at 12 months, NERS was associated with
improvements in physical activity for patients at risk of
coronary heart disease, but not for those referred for an-
xiety and depression, despite an improvement in their
mental health [7]. The evaluation also showed the base-
case incremental cost-effectiveness ratio was £12,111 per
quality-adjusted life year (QALY), falling to £9741 if par-
ticipants were to contribute £2 per session [7]. Qualitative
data highlighted a need for post-intervention motivational
support to maintain changes [7, 8]. Whilst there is evi-
dence for effectiveness of ERS in increasing physical activ-
ity in the short term [9–11], evidence of long-term
effects is limited. The Department of Health’s Quality
Assurance Framework for Exercise Referral [12] high-
lights the need to understand how to support long-
term maintenance of changes in physical activity.
On entry to an ERS, patients may be initially moti-
vated by external sources such as GP advice to attend
[13, 14]. However, sustained changes in physical activity
are consistently associated with more internalised, or
autonomous, motivation [15–17]. According to self-
determination theory [18], the development of autono-
mous motivation can be achieved through supporting
psychological needs for autonomy (volitional and self-
endorsed engagement), competence (personal mastery
and effectiveness) and relatedness (meaningful interper-
sonal connections). Thus, developing ways to support
these three needs should help to maintain changes in
physical activity. Support for this notion is provided by
the randomised controlled trial of the Welsh NERS
which found increases in autonomous motivation after
scheme exit. This increase explained almost half of the
between-group difference in physical activity 6 months
later [19]. Integrating processes to further enhance and
sustain autonomous motivation during and after in-
volvement in an exercise referral scheme may lead to
larger effects and longer-term maintenance of these.
Existing evidence points to potential motivational effects
of techniques such as goal setting, monitoring and per-
sonalised feedback on progress towards goals [20, 21]
which may support autonomous motivation by enhancing
patients’ sense of mastery and competence and are
recommended by NICE as core components of behaviour
change interventions [22].
Technologies such as activity monitors provide oppor-
tunities to enhance delivery of goal setting and feedback,
allowing for more frequent and automatic feedback on
progress towards activity goals, tailored updating of
goals based on achievement and remote contact with
intervention providers [23]. In addition to addressing
psychological needs for competence, incorporation of
social components may support motivation through pro-
moting relatedness to other service users. Research on
such technologies in exercise interventions suggests that
use can be quickly integrated in participants’ lives [24]
and may increase physical activity levels [25–29]; how-
ever, overall, the evidence is equivocal [23]. Furthermore,
little is known about the acceptability of these technolo-
gies to ERS populations or if the benefits will remain once
the initial novelty has ceased. Exercise referral patients are
a diverse group with a range of ages and conditions. For
example, although the average age of participants in the
evaluation of the Welsh NERS was 52 years old, the over-
all ages ranged from 16 to 88. Thus, familiarity with tech-
nology and willingness to use it may differ within the
group [30]. In addition, participant diversity in terms of
socioeconomic status and geographic location may re-
sult in differences in access to high-speed internet con-
nections or the hardware required for engaging with
some technologies (e.g. personal computer). Hence,
prior to a trial of effectiveness, which may be under-
mined by difficulties integrating technologies into rou-
tine practice or facilitating uptake by patients, piloting
is required to investigate these issues.
A preliminary investigation [31] tested a protocol for
integrating activity monitoring devices (MyWellness-
Key, Technogym) and a linked web platform in one
local authority area of the Welsh NERS. The study
showed potential for using the MyWellnessKey (MWK)
devices in the scheme; however, further work is re-
quired to understand the feasibility and acceptability of
this on a larger scale with a demographically diverse
population. In this paper, we describe the protocol of
the PACERS study, a pilot trial to assess the feasibility
and acceptability of using the MWK activity monitors
to promote maintenance of physical activity within
NERS. The aim of the study is to evaluate the feasibility
and acceptability of the intervention (the MWK) and its
proposed evaluation methodology, in order to optimise
design and delivery and evaluate whether a full-scale
randomised controlled trial of effectiveness is war-
ranted and feasible.
Study aim
The primary aim of the study is to assess the feasibility
and acceptability of implementing the MWK activity
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monitors within the Welsh NERS as well as the proposed
evaluation methodology in order to optimise design and
delivery for conducting a definitive evaluation trial.
Study objectives
The main objectives for this study are to investigate:
a) the fidelity of delivery of the intervention and trial
methodology including compliance with study
invitation and randomisation processes;
b) the acceptability of the intervention to participants
in terms of its usability and likelihood of future use;
c) whether randomisation is acceptable to 50% or more
of participants;
d) the feasibility of recruiting 20% or more new NERS
patients and retaining at least 80% of participants at
12-month follow-up (T2);
e) contamination, by exploring whether less than 20%
of control participants are exposed to the
intervention;
f ) the effect of the intervention on the main
hypothesised change mechanism (autonomous
motivation); and
g) the feasibility of collecting the primary, secondary
and process outcome measures and economic
evaluation methods.
Methods
Study design
The study design is an individually randomised pilot
randomised controlled trial, plus a process evaluation
and exploratory economic analyses, of implementing the
MWK devices within Welsh NERS standard practice.
Data will be collected at three time points: baseline (time
0 (T0)), at the end of the 16-week NERS programme
(T1) and 12-months post-baseline (T2). Figure 1 shows
the study flow diagram. The study was given favourable
ethical opinion for conduct in the NHS on 1 December
2015 by the South East Scotland Research Ethics Com-
mittee 02 (REF: 189587).
Setting and participants
The study is being undertaken within the Welsh NERS
across leisure centres in eight local authority areas in
Wales, UK. The eight study sites were purposively se-
lected to reflect a range of urbanisation and geography.
Participants are eligible for the study if they (i) are re-
ferred into the NERS generic pathway (see Table 1) and
(ii) have the capacity to use the activity monitors (i.e.
computer access and an email address).
Recruitment
Participants will be recruited to the trial using opportun-
istic invites within the existing scheme structure. NERS
exercise professionals will provide information about the
study to all new generic pathway clients during their first
consultation appointment on the scheme. Exercise pro-
fessionals will transfer the contact details of clients who
are eligible for and interested in joining the study to the
research team using a secure electronic form. The re-
search team will send a recruitment pack containing full
informed consent materials and the baseline question-
naire to interested clients to be returned by post. Partici-
pants who return a signed consent form and completed
baseline questionnaire will be entered into randomisa-
tion. Participants in the intervention group will be sent
information about the process evaluation interviews fol-
lowing randomisation and will be asked to express an
interest in taking part in the interviews. From those who
express an interest, participants will be selected to pro-
vide variation in local authority area, age, sex and reason
for referral. Where possible, we will interview the same
participants at 4 weeks and 12 months. Where not pos-
sible, additional participants matched by demographics
(e.g. age and sex) will be recruited for 12-month inter-
views. All NERS staff involved in the study will be in-
vited to participate in the process evaluation interviews.
From those who express an interest, two staff members
per local authority area will be selected.
Randomisation
After completion of baseline measures, study staff will
randomly assign participants 1:1 to receive either the
intervention (NERS plus MWK) or the control treat-
ment (NERS standard practice) via a computer-
generated random allocation sequence created by the
South East Wales Trials Unit.
The intervention
The intervention is an enhanced ERS that includes usual
care (NERS standard practice) [6] plus an
accelorometry-based activity monitor (MyWellnessKey;
MWK). The MWK can be used for self-monitoring of
physical activity levels in combination with a linked web
platform (MyWellnessCloud) and smartphone applica-
tion (see Table 2). The MWK has been validated in
terms of device accuracy at monitoring physical activity
level and intensity [32, 33] and utility at fostering in-
creased physical activity levels (high concurrent validity
with ActiGraph accelerometer to detect physical activity
in laboratory and free-living environments) [34].
Intervention participants will be provided with a
MWK to use for the remaining 12 weeks of their 16-
week NERS programme after receiving it at their 4-week
consultation and will be encouraged to use it for
36 weeks after they exit the scheme, up until their 12-
month consultation when the device will be returned. In
current practice, conducting an 8-month telephone
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consultation to check clients’ progress with exercise is
an optional part of standard care. To encourage partici-
pants to maintain engagement in the study, we have
asked for the telephone consultation to take place with
all intervention participants. Table 3 shows how the
intervention will be implemented within the scheme.
It is anticipated that the intervention will enhance
NERS through two key mechanisms: (1) goal setting and
personalised feedback elements of the devices will sup-
port a sense of exercise mastery and perceived compe-
tence; (2) the web platform will provide a sense of
relatedness to others via opportunities to communicate
remotely with exercise professionals, other NERS clients
and social media contacts. It is anticipated that these
mechanisms will improve autonomous motivation for
exercise, leading to greater maintenance of increases in
physical activity, as depicted in the intervention logic
model (see Fig. 2).
Control treatment
Control participants will receive usual care which is
NERS standard practice: a 16-week structured exercise
programme which includes consultations with an exer-
cise professional at the start, 4 weeks, on exiting the
scheme (16 weeks) and at 12-month follow-up [6].
Primary outcome
The primary outcome will be the feasibility and accept-
ability of the intervention and its proposed evaluation
methodology, to inform a decision on whether a full
Fig. 1 Flow diagram of the PACERS study design
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randomised controlled trial is warranted and feasible.
This will be assessed against a set of predefined progres-
sion criteria related to recruitment and retention rates,
exposure to the intervention in both intervention and
control groups and acceptability of the intervention, re-
cruitment and randomisation processes to participants.
The criteria were agreed by the Trial Steering Commit-
tee (TSC) and follow a traffic light assessment system
(red = stop; amber = discuss with TSC whether there is
enough evidence that sufficient improvements can be
made to proceed to full trial without another feasibility
assessment; green = proceed) using quantitative mea-
sures supported by qualitative data. The criteria, their
measurement and assessment criteria are summarised in
Table 4. Qualitative data will provide insights into inter-
vention and evaluation design features which need to be
retained, or where metrics fall into the amber zone,
modifications which may need to be made to improve
feasibility and acceptability.
It is anticipated that in a full trial, the main outcome
measure will be objectively measured physical activity
using accelerometry. To examine the feasibility of collec-
ting this data at follow-up in the NERS population, a sub-
sample of participants will be recruited to complete the
accelerometer measure at 16 months post-randomisation.
Participants will wear a GT3X ActiGraph accelerometer
around the waist for seven consecutive days during wa-
king hours. Data will be processed to identify mean mi-
nutes of moderate to vigorous intensity activity per day
and mean accelerometer counts per minute (volume of
physical activity) using established processes [35].
Secondary outcomes
The effect of the intervention on the main hypothesised
change mechanism (autonomous motivation) will be
evaluated. Other secondary outcome measures will be
piloted to estimate key trial parameters (e.g. standard de-
viation) to inform a future full trial.
Measures collected routinely in NERS
Data collected routinely within NERS will be obtained
for use within the trial from T0, T1 and T2, as follows:
 Blood pressure and resting heart rate;
 Body mass index;
 Waist circumference;
 Self-reported physical activity (Scottish Physical
Activity Questionnaire) [36];
 Health-related quality of life (EQ-5D-5L) [37]; and
 Fitness test (Chester fitness test) [38].
Measures included in PACERS study questionnaire
The following additional measures will be collected at all
time points, which in a full trial would be used to assess
effectiveness of the added intervention component
(MyWellnessKey):
 Autonomous Motivation (Behavioural Regulation
in Exercise Questionnaire 3 (BREQ-3)) [39];
 Psychological need support (Intrinsic Motivation
Inventory) [40];
 Anxiety and depression (Hospital Anxiety and
Depression Scale (HADS)) [41].
Economic evaluation outcome measures
The PACERS study questionnaire will include an
adapted Client Service Receipt Inventory (CSRI) based
on the previous service use questionnaire used in the
NERS evaluation [7] and examples in the DIRUM data-
base (dirum.org) to capture client health and social care
service use since the last time point (plus a 4 month
retrospective period at baseline). Additional questions in
the 12-month questionnaire will capture wider economic
Table 1 NERS Generic Pathway Criteria
For referral into the NERS generic pathway, patients must:
- Be aged 16 years or above;
- Be sedentary (defined as not moderately active for 3 times per
week or deconditioned through age or inactivity);
- Have at least one of the following:
○ Raised blood pressure 140/90,
○ BMI > 28,
○ Cholesterol > 5.0,
○ Controlled diabetes or impaired glucose intolerance,
○ Family history of heart disease or diabetes,
○ At risk of osteoporosis and/or musculoskeletal pain,
○ Mild arthritis or poor mobility,
○ Mild-moderate COPD, asthma, bronchitis, emphysema,
○ Mild anxiety, depression or stress, multiple sclerosis.
Table 2 Features of the MWK activity monitor and
MyWellnessCloud web platform
• Real-time visual feedback via a screen on the activity monitor
• Detailed feedback on activity levels via a web platform to indicate
progress towards goals, time spent in different activity intensities
and calories burned
• Automatised goal setting via an algorithm which sets goals in a
stepwise fashion such that forward progression is mastery-based
• Facilitation of social support for exercise via the web platform
(through involvement in group challenges and remote communication
with an exercise professional) and smartphone app (the option to share
details about activity completed via social media)
• Free access to the web platform and smartphone application following
discontinuation of use of the MWK via manual input or by linking the
account to another monitoring device.
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outcomes including current work status, days off work
due to health problems and estimated income lost due
to changes in work during the study period. Willingness
to pay for the MWK will also be explored. Baseline
demographic data on housing status and household in-
come will also be collected in the PACERS study ques-
tionnaire for the purpose of the economic analysis.
Sample size
The proposed sample size for the study of 286 partici-
pants was calculated to allow the estimation of the feasi-
bility proportions of adherence and retention to within
at least plus or minus 8.2 percentage points using a 95%
confidence interval, as well as to provide 80% power to
detect an effect size of 0.4 at the 5% level on the main
Table 3 Implementation of the intervention components
Time point Exercise professionals Intervention participants
At 4 week review appointment Set up participants with a MWC account, configure
initial activity goals on the MWK and demonstrate
how to use the device and web platform.
Take the MWK home, sign into their MWC account on
their home computer and connect their MWK to read
data and charge it.
Over the study period (48 weeks) Interact with participants to monitor and adjust their
goals, send positive comments and set up group
challenges through direct messaging via a linked
website called Professional Cloud.
Use the device daily and connect the MWK to a
computer at least twice per week to upload data to the
MWC, receive feedback and charge the device.
Manually enter information about activity that the
device does not readily measure, i.e. swimming, weight
training, cycling.
At 8 months from start Telephone participants to check on their progress
with exercising and remind them of the study and
encourage use of the MWK, MWC and associated
features.
Participants with a MWK continue to use it daily.
At 12 months from start Exercise professionals will have a consultation with
all participants for usual NERS assessments and to
collect the MWK.
Hand the MWK back to the exercise professional.
Fig. 2 PACERS logic model
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hypothesised mediator of autonomous motivation at 12-
month follow-up, assuming 30% attrition [7]. The sam-
ple size was also planned to provide an indication of
likely response rates, permit estimates of effect sizes of
primary and secondary outcomes in advance of a larger
trial and allow exploration of socio-demographic pat-
terning in uptake and use of the MWKs in order to gen-
erate hypotheses regarding who the intervention might
work for and why.
Data collection
Routinely collected data will be extracted from the NERS
database at all T0, T1 and T2. The PACERS study ques-
tionnaire will be mailed to participants at all time points.
Telephone and email reminders will be made to non-
responders. Semi-structured telephone interviews will be
conducted with a sub-sample of intervention partici-
pants (n = 20) following receipt of the intervention at
4 weeks and again at 12 months (T2) to explore feasibil-
ity and acceptability of the intervention and study
methods. In addition, telephone interviews will be con-
ducted with a sample of NERS exercise professionals at
the same time points to explore feasibility and accept-
ability of implementing the intervention and study
methods from a professional perspective. Figure 3 indi-
cates the schedule of enrolment, interventions and
assessments.
Process evaluation
A detailed process evaluation will examine the accep-
tability and feasibility of the intervention and evaluation
methods, including intervention delivery and fidelity, po-
tential contamination and contextual influences. Quan-
titative and qualitative data will be collected using a
range of methods. Table 5 summarises the process evalu-
ation methods.
Economic analysis methods
Data will be collected to estimate intervention costs and
examine the feasibility of calculating cost-effectiveness
Table 4 Summary of progression criteria
Progression criteria (PC) Measures used Assessment of whether criteria have been met
PC1. Feasibility to recruit a sufficient proportion
of new NERS patients to participate in the trial,
with appropriate retention rates to 12-month
follow-up.
• The percentage of new NERS patients
recruited to the trial, and retained at each
subsequent follow-up.
• Regression models will be used to identify
predictors of loss to follow-up (e.g.
demographics or baseline motivation).
• If > 20% of new NERS patients recruited =
proceed; if < 5% = full-scale trial unlikely to be
feasible. If 5–20% the TSC will consider the
feasibility of proceeding to a full-scale trial
bearing in mind the data and feedback
presented and representativeness of the
recruited sample, and possible steps to increase
the recruitment rate.
• If > 80% retained at 12-months = proceed,
if < 60% = full-scale trial unlikely to be feasible. If
60–80% the TSC will consider the feasibility of
proceeding based on the available data and
possible steps to increase retention.
PC2. Intervention and trial methodology
delivered as intended
• Summary statistics for intervention fidelity
measures overall and by area.
• Compliance with study invite processes.
• Compliance with randomisation processes.
• The TSC will consider the data presented and
make a judgement about whether the
intervention and trial methodology were
delivered as intended.
PC3. At least one of the two intervention
components is acceptable to participants
• Percentages of participants who report
acceptability of the intervention components
on four self-report questions.
• Issues regarding acceptability of, and
engagement with, the two intervention
components explored in qualitative interviews
with a sub-sample of intervention participants.
• The TSC will consider the quantitative and
qualitative data and make an overall judgement
on whether the intervention is acceptable.
PC4. Recruitment and randomisation processes
acceptable to > 50% of recruited participants
• Percentages of participants who report
acceptability of the recruitment and
randomisation processes on patient
questionnaires.
• Exploration of understanding and acceptability
of recruitment and randomisation processes in
qualitative interviews.
• > 50% of recruited participants report ‘agree’ or
‘strongly agree’ to questions about the
acceptability of recruitment and randomisation
processes.
• The TSC will apply discretion in judging whether
this criterion has been met, or could be
addressed to improve acceptability in a full-scale
trial.
PC5. < 20% of control group exposed to the
intervention components
• The percentage of participants in intervention
and control groups who report that they were
provided with a MWK device or accessed the
MWC web platform.
• < 20% of control participants report that they
have used a MWK device during the study
period.
• < 20% of control participants report that they
have accessed the MWC during the study period.
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alongside a definitive full pragmatic randomised trial.
Health care service use will be costed using national
unit costs [42, 43]. Both arms of the study with be
costed, revisiting and revising the costing method-
ology used in previous economic analysis of the Welsh
NERS [44].
The additional costs of the intervention will consist
of the cost of the MWK; staff costs relating to the
MWK (e.g. training, implementation and participant
follow-up support); the cost of the professional web
cloud (e.g. licence fee) and additional staff interactions.
These costs are in addition to the core programme
costs (in both arms) including NERS standard practice
costs and participant contributions. Information about
the additional staff resources required for the use of the
MWK and professional web cloud will be derived from
qualitative interviews with staff.
Data analysis
Quantitative analysis
The main outcomes in this feasibility study are related
to the study progression criteria as outlined in Table 4.
The methods of analysis for quantitative data collected
for the process evaluation are summarised in Table 5.
Analyses will be largely descriptive, with summary sta-
tistics being presented overall and also by key demo-
graphics. Evidence of whether the intervention could
lead to behaviour change will be examined using re-
gression analyses to quantify effects on autonomous
motivation, using the Relative Autonomy Index derived
from the BREQ-3.
To examine the direction of effect on physical activ-
ity, analysis of covariance models [ANCOVA] will be
used to estimate intervention effects on physical activ-
ity at 16 months. Whilst likely non-significant due to
TIMEPOINT Pre-baseline
Baseline 
(Month 0)
1-month 4-months 12-months 16-months
ENROLMENT:
Eligibility screen X
Expression of interest X
Informed consent X
Allocation X
INTERVENTION:
NERS+MWK
Control (NERS only)
ASSESSMENTS:
Self-reported physical activity 
[SPAQ] X X X
Health-related quality of life 
[EQ5D5L] X X X
Fitness test X X X
Blood pressure X X X
Body mass index X X X
Waist circumference X X X
Autonomous motivation 
[BREQ-3] X X X
Psychological need support 
[IMI] X X X
Anxiety and depression 
[HADS] X X X
Process evaluation interview 
[sub-sample] X X X X
Objectively measured 
physical activity [subsample] X
Fig. 3 PACERS study schedule of enrolment, interventions and assessments. Black-coloured X indicates study participants and red-coloured
X indicates intervention delivery staff
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limited power, this should be in the direction of a
favourable intervention effect. Accelerometer data will be
processed using standard procedures; periods of ≥ 60 min
of zero counts will be recorded as “non-wear time” and re-
moved. Participants will be included in the analysis if they
provide ≥ 3 valid days (i.e. 500 min of data between 6 am
and 11 pm). Mean minutes of daily moderate to vigorous
intensity activity will be estimated using a threshold value
of ≥ 2020 counts per minute with minutes of light inten-
sity physical activity estimated using thresholds of be-
tween 100 and 2019 counts per minute [35]. Sedentary
time will be estimated based on a cut-point of less than
100 counts per minute; mean sedentary minutes per day
will be derived.
Qualitative analysis
Qualitative data from interviews with exercise profes-
sionals and intervention participants will be transcribed
verbatim and organised and coded into a thematic
framework using NVivo 11 software. An approach to
thematic analysis will be used that allows for both a de-
ductive and inductive approach to data analysis [45].
Data will be initially coded using an a priori coding
scheme of categories which align with the research ques-
tions as a means of organising the data for subsequent
interpretation. An element of flexibility will be main-
tained to account for the emergence of any new and un-
expected themes. The first three transcripts will be
independently coded by two coders in order to develop
a shared codebook via consensus. Any disagreements be-
tween coders will be discussed with a third coder. Diver-
gence and convergence between interviews will be
examined and comparisons made of the experiences of
the intervention across and within areas (NERS clients
and exercise professionals). We aim to develop a com-
prehensive understanding of the intervention acceptabil-
ity, implementation and mechanisms of impact.
Economic analysis
A pilot cost-consequence analysis will be conducted
from a NHS and societal perspective. Response rates
and level of completion of the measures will be re-
ported using descriptive statistics. Variables will be
checked for out of range values before analysis begins.
As data are expected to be skewed, non-parametric
tests will be used to assess differences across groups or
time points for the outcomes of QALYs (using the EQ-
5D) and health and social care service use. We will
bootstrap (5000 replications) differences in cost and
outcomes to produce a 95% confidence interval around
these differences. Ceiling effects on the EQ-5D will also
be assessed, assessing the proportion of participants
that state “no problems” on all five dimensions on the
EQ-5D questionnaire. QALY gains (using the EQ-5D)
will be compared to those in similar samples from pre-
vious literature (where available).
A report on the data gathered about service use (from
routinely collected data recorded by healthcare profes-
sionals delivering NERS) will explore if future studies
could use this or a different method to the CSRI ques-
tionnaire used in the feasibility study. Descriptive statis-
tics will be used to describe the amount participants are
willing to pay for the MWK, both during the interven-
tion and beyond. Response rates and level of completion
of the questions exploring how best to capture product-
ivity losses will be reported using descriptive statistics.
Sub-group analyses will explore the effect on health-
related quality of life of socio-demographics (e.g. gender)
and reason for referral. Sensitivity analysis will be con-
ducted in accordance with NICE guidelines to vary the
cost of the device [46], demonstrating what happened in
the feasibility trial and how co-ordination may be varied
in a future full-scale trial.
Serious adverse event reporting and monitoring
It is not anticipated that there will be any additional
risks to participants over and above existing NERS
standard practice for which standard operating proce-
dures are in place covering referral into the scheme,
provision of exercise instruction and support, and deal-
ing with adverse events. There are no serious adverse
events expected to be related to the intervention. Any
serious adverse event occurrence will be reported to the
Chief Investigator within 48 h of receiving notification.
Assignment of causality will be made by the independent
clinician member of the TSC.
Project management
A Trial Management Group (TMG) is responsible for
ensuring the appropriate, effective and timely implemen-
tation of the trial including monitoring adherence to
standardised research protocols. The day-to-day oper-
ational management of the feasibility study is co-
ordinated by a central project management team which
meets weekly to monitor progress and any issues which
may need relaying to the TMG. An independent TSC
provides overall supervision for the trial and advice
through its independent chair and also encompasses the
role of Data Monitoring Committee.
Discussion
The PACERS feasibility trial aims to assess the feasibi-
lity and acceptability of implementing a novel mo-
tivational component, the MyWellnessKey, into the
existing Welsh NERS. In addition, the trial also aims to
determine the acceptability and feasibility of the pro-
posed evaluation methodology for a definitive trial of
the intervention for promoting long-term maintenance
Hawkins et al. Pilot and Feasibility Studies  (2017) 3:51 Page 10 of 12
of physical activity. Whilst exercise referral approaches
have been shown to be effective for increasing physical
activity levels, evidence of long-term effects is limited
[9, 10, 12] and so there is a need to better understand
how to support long-term maintenance of physical ac-
tivity [3]. The MWK intervention offers a potential
mechanism for enhancing and sustaining autonomous
motivation for physical activity via evidence-based tech-
niques including goal setting, self-monitoring and re-
ceiving personalised feedback on progress towards
goals [20–22].
Findings from this study will determine whether pro-
gression to a full-scale randomised controlled trial of
effectiveness and cost-effectiveness is feasible and war-
ranted, through the assessment of key progression cri-
teria. The study will assess whether the outcomes being
used are feasible and acceptable to use with the study
population. Findings related to the acceptability and
feasibility of implementing the intervention will inform
potential refinement of the implementation processes
where necessary. The findings will also allow refine-
ment of the intervention logic model.
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